HBP1 and neoplasm: It has previously been established that HBP1 is a target of the retinoblastoma pathways [70,71] and that HBP1 negatively regulates Wnt/β-catenin, thus inhibiting proliferation and suggesting that HBP1 may have a tumour suppressor function [72].